Literature DB >> 18246002

ISSLS prize winner: repeated disc injury causes persistent inflammation.

Jill A Ulrich1, Ellen C Liebenberg, Daniel U Thuillier, Jeffrey C Lotz.   

Abstract

STUDY
DESIGN: An in vivo rat model of disc degeneration with emphasis on characterizing acute and chronic cytokine production.
OBJECTIVE: To compare the morphologic and proinflammatory response between a single and triple-stab injury in attempts to establish mechanisms of chronic disc inflammation. SUMMARY OF BACKGROUND DATA: The features that distinguish physiologic (asymptomatic) from pathologic (symptomatic) degeneration are unclear. Epidemiologic evidence suggests that cumulative damage and elevated disc cytokine levels may be linked to increased low back pain rates. Although acute injury stimulates a healing response that includes transient cytokine production, repetitive damage may be necessary to trigger the persistent inflammation suspected to underlie chronic pain.
METHODS: Tail discs were exposed surgically and stabbed with a number 11 blade. During the subsequent acute healing phase, triple-stab discs were percutaneously injured with a 23-gauge needle at day 3 and then again at day 6 after the initial blade incision. Cytokine (IL-1 beta, IL-6, IL-8, and TNF-alpha) production was quantified using enzyme linked immunosorbent assay, and, in addition to MAPK signaling pathways (phosphorylated forms of ERK, JNK, and p38), was localized by immunohistochemistry. Disc architecture was evaluated using histology.
RESULTS: Both single-stab and triple-stab discs degenerated with time, yet degeneration was more severe with repeated injury where nuclear proteoglycan was replaced by disorganized collagen. Four days after single-stab, there was a transient peak in IL-1 beta and IL-8 production that was localized to the wound track and associated granulation tissue. By contrast, triple-stab induced an activated annular fibroblast phenotype (p38 positive) that caused a prolonged, diffuse inflammatory response with elevated levels of TNF-alpha, IL-1 beta, and IL-8 up to 28 days after injury. Disc inflammation was accompanied by reactive changes in the adjacent vertebral marrow spaces that was initially lytic at day 4, becoming sclerotic by day 56.
CONCLUSION: Our results demonstrate that repeated injury during active healing leads to persistent inflammation and enhanced disc degeneration. These data support the premise that damage accumulation and its associated inflammation may distinguish pathologic from physiologic disc degeneration. In the future, this triple-stab model may be useful to evaluate the efficacy of anti-inflammatory low back pain treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18246002     DOI: 10.1097/BRS.0b013e31815b9850

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  69 in total

1.  Reduced tissue osmolarity increases TRPV4 expression and pro-inflammatory cytokines in intervertebral disc cells.

Authors:  B A Walter; D Purmessur; A Moon; J Occhiogrosso; D M Laudier; A C Hecht; J C Iatridis
Journal:  Eur Cell Mater       Date:  2016-07-19       Impact factor: 3.942

2.  Structured coculture of stem cells and disc cells prevent disc degeneration in a rat model.

Authors:  Aliza A Allon; Nicolas Aurouer; Bryan B Yoo; Ellen C Liebenberg; Zorica Buser; Jeffrey C Lotz
Journal:  Spine J       Date:  2010-10-25       Impact factor: 4.166

Review 3.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

Review 4.  Pathobiology of Modic changes.

Authors:  Stefan Dudli; Aaron J Fields; Dino Samartzis; Jaro Karppinen; Jeffrey C Lotz
Journal:  Eur Spine J       Date:  2016-02-25       Impact factor: 3.134

5.  Mitochondrial-derived reactive oxygen species (ROS) play a causal role in aging-related intervertebral disc degeneration.

Authors:  Luigi A Nasto; Andria R Robinson; Kevin Ngo; Cheryl L Clauson; Qing Dong; Claudette St Croix; Gwendolyn Sowa; Enrico Pola; Paul D Robbins; James Kang; Laura J Niedernhofer; Peter Wipf; Nam V Vo
Journal:  J Orthop Res       Date:  2013-02-06       Impact factor: 3.494

Review 6.  New challenges for intervertebral disc treatment using regenerative medicine.

Authors:  Koichi Masuda; Jeffrey C Lotz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

7.  Associations between vertebral body fat fraction and intervertebral disc biochemical composition as assessed by quantitative MRI.

Authors:  Roland Krug; Gabrielle B Joseph; Misung Han; Aaron Fields; Justin Cheung; Maya Mundada; Jeannie Bailey; Alice Rochette; Alexander Ballatori; Charles E McCulloch; Zachary McCormick; Conor O'Neill; Thomas M Link; Jeffrey Lotz
Journal:  J Magn Reson Imaging       Date:  2019-01-30       Impact factor: 4.813

8.  Disc cell therapy with bone-marrow-derived autologous mesenchymal stromal cells in a large porcine disc degeneration model.

Authors:  G W Omlor; S Lorenz; A G Nerlich; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2018-08-23       Impact factor: 3.134

9.  Inflammatory cytokine and catabolic enzyme expression in a goat model of intervertebral disc degeneration.

Authors:  Chenghao Zhang; Sarah E Gullbrand; Thomas P Schaer; Yian Khai Lau; Zhirui Jiang; George R Dodge; Dawn M Elliott; Robert L Mauck; Neil R Malhotra; Lachlan J Smith
Journal:  J Orthop Res       Date:  2020-03-03       Impact factor: 3.494

10.  A large animal model that recapitulates the spectrum of human intervertebral disc degeneration.

Authors:  S E Gullbrand; N R Malhotra; T P Schaer; Z Zawacki; J T Martin; J R Bendigo; A H Milby; G R Dodge; E J Vresilovic; D M Elliott; R L Mauck; L J Smith
Journal:  Osteoarthritis Cartilage       Date:  2016-08-26       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.